Annual maintenance and repair of ORA's fleet of vitek and vidas equipment

Ended Awarded Last action

Contract number
75F40123F19003
Awardee
Awarding agency
Obligated
$20,805

Award facts

Contract value 200% obligated
$10,402.64 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Competed under SAP Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Jamaica, NY 11433, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00001 -$10,403
Original award $20,805

About this award

On November 7, 2022, the Food and Drug Administration (FDA) awarded a delivery order valued at $10,402.64 to Biomerieux Inc. for annual maintenance and repair services of the agency's fleet of VITEK and VIDAS diagnostic equipment located in Jamaica, NY. The contract was awarded on a firm fixed-price basis with no set-aside designation and is scheduled for completion by April 29, 2023. Biomerieux Inc., operating through its Vitek Systems, Inc. division, is a global leader in in vitro diagnostics and microbiological testing solutions, providing the FDA and other federal agencies with advanced diagnostic platforms, reagents, and associated maintenance services.

This delivery order represents a component of Biomerieux's extensive portfolio of federal diagnostic equipment contracts, which collectively exceed $30 million across multiple federal agencies including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and National Institutes of Health. The company maintains numerous indefinite delivery vehicles and blanket purchase agreements with federal healthcare agencies that enable efficient procurement of diagnostic equipment, consumables, and maintenance services on an as-needed basis. The maintenance and repair services covered under this FDA delivery order support the agency's laboratory operations and ensure continued functionality of critical microorganism identification and immunoassay testing systems.

Quick answers

Who was awarded contract 75F40123F19003?

75F40123F19003 was awarded to Biomerieux Inc. by Food and Drug Administration (Department of Health and Human Services) on November 7, 2022.

How much is contract 75F40123F19003 worth?

The government has obligated $20,805 on 75F40123F19003. Its current value, with exercised options, is $10,403.

Is contract 75F40123F19003 an order under another contract?

Yes. 75F40123F19003 is a delivery order under 75F40121D00012, an indefinite delivery contract.

Was contract 75F40123F19003 competed?

The extent of competition for 75F40123F19003 was competed under sap.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award